FDA warns of death, liver injury risks from Intercept's drug

(Reuters) - The U.S. Food and Drug Administration (FDA) warned on Thursday that Intercept Pharmaceuticals Inc's drug Ocaliva was being incorrectly dosed in some patients with a rare liver disease, increasing the risk of liver injury and death.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news